vs
Side-by-side financial comparison of Atara Biotherapeutics, Inc. (ATRA) and ELECTRO SENSORS INC (ELSE). Click either name above to swap in a different company.
ELECTRO SENSORS INC is the larger business by last-quarter revenue ($2.8M vs $1.6M, roughly 1.7× Atara Biotherapeutics, Inc.). On growth, ELECTRO SENSORS INC posted the faster year-over-year revenue change (14.8% vs -95.1%). Over the past eight quarters, ELECTRO SENSORS INC's revenue compounded faster (10.8% CAGR vs -75.9%).
Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic T-cell immunotherapies for patients with unmet medical needs across oncology, autoimmune disease, and infectious disease indications. It operates primarily in North America, Europe, and Asia-Pacific, partnering with research institutions to advance its novel treatment pipeline.
Polar Electro Oy is a Finnish manufacturer of sports training computers, particularly known for developing the world's first wireless heart rate monitor.
ATRA vs ELSE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $2.8M |
| Net Profit | — | $103.0K |
| Gross Margin | — | 50.3% |
| Operating Margin | — | -0.3% |
| Net Margin | — | 3.7% |
| Revenue YoY | -95.1% | 14.8% |
| Net Profit YoY | 73.2% | -48.8% |
| EPS (diluted) | — | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $2.8M | ||
| Q3 25 | $3.5M | $2.7M | ||
| Q2 25 | $17.6M | $2.4M | ||
| Q1 25 | $98.1M | $2.2M | ||
| Q4 24 | $32.8M | $2.4M | ||
| Q3 24 | $40.2M | $2.5M | ||
| Q2 24 | $28.6M | $2.2M | ||
| Q1 24 | $27.4M | $2.2M |
| Q4 25 | — | $103.0K | ||
| Q3 25 | $-4.3M | $208.0K | ||
| Q2 25 | $2.4M | $59.0K | ||
| Q1 25 | $38.0M | $-64.0K | ||
| Q4 24 | $-12.7M | $201.0K | ||
| Q3 24 | $-21.9M | $238.0K | ||
| Q2 24 | $-19.0M | $-4.0K | ||
| Q1 24 | $-31.8M | $11.0K |
| Q4 25 | — | 50.3% | ||
| Q3 25 | — | 53.1% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 49.6% | ||
| Q3 24 | — | 50.4% | ||
| Q2 24 | — | 47.2% | ||
| Q1 24 | — | 48.1% |
| Q4 25 | — | -0.3% | ||
| Q3 25 | -103.5% | 6.6% | ||
| Q2 25 | 18.2% | -0.1% | ||
| Q1 25 | 39.5% | -7.5% | ||
| Q4 24 | -37.3% | 1.3% | ||
| Q3 24 | -54.1% | 6.9% | ||
| Q2 24 | -63.7% | -4.8% | ||
| Q1 24 | -114.2% | -4.5% |
| Q4 25 | — | 3.7% | ||
| Q3 25 | -124.6% | 7.6% | ||
| Q2 25 | 13.6% | 2.5% | ||
| Q1 25 | 38.7% | -2.9% | ||
| Q4 24 | -38.8% | 8.4% | ||
| Q3 24 | -54.5% | 9.5% | ||
| Q2 24 | -66.5% | -0.2% | ||
| Q1 24 | -116.1% | 0.5% |
| Q4 25 | — | $0.03 | ||
| Q3 25 | $-0.32 | $0.06 | ||
| Q2 25 | $0.19 | $0.02 | ||
| Q1 25 | $3.50 | $-0.02 | ||
| Q4 24 | $0.27 | $0.06 | ||
| Q3 24 | $-2.93 | $0.07 | ||
| Q2 24 | $-3.10 | $0.00 | ||
| Q1 24 | $-5.65 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $10.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-38.5M | $14.8M |
| Total Assets | $20.2M | $15.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | $10.6M | ||
| Q3 25 | $13.7M | $10.6M | ||
| Q2 25 | $22.3M | $10.2M | ||
| Q1 25 | $13.8M | $10.0M | ||
| Q4 24 | $42.5M | $10.0M | ||
| Q3 24 | $67.2M | $10.3M | ||
| Q2 24 | $35.3M | $9.9M | ||
| Q1 24 | $46.2M | $10.1M |
| Q4 25 | $-38.5M | $14.8M | ||
| Q3 25 | $-36.6M | $14.7M | ||
| Q2 25 | $-35.0M | $14.4M | ||
| Q1 25 | $-55.1M | $14.3M | ||
| Q4 24 | $-97.3M | $14.3M | ||
| Q3 24 | $-90.5M | $14.1M | ||
| Q2 24 | $-110.9M | $13.8M | ||
| Q1 24 | $-98.3M | $13.8M |
| Q4 25 | $20.2M | $15.7M | ||
| Q3 25 | $30.2M | $15.7M | ||
| Q2 25 | $36.9M | $15.2M | ||
| Q1 25 | $62.0M | $15.1M | ||
| Q4 24 | $109.1M | $14.9M | ||
| Q3 24 | $142.7M | $15.0M | ||
| Q2 24 | $117.3M | $14.5M | ||
| Q1 24 | $165.3M | $14.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.9M | $20.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 0.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.9M | $20.0K | ||
| Q3 25 | $-9.8M | $395.0K | ||
| Q2 25 | $-7.3M | $277.0K | ||
| Q1 25 | $-28.1M | $-30.0K | ||
| Q4 24 | $-24.5M | $-277.0K | ||
| Q3 24 | $-4.0M | $362.0K | ||
| Q2 24 | $-10.6M | $-158.0K | ||
| Q1 24 | $-29.6M | $202.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | $389.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-24.6M | $-298.0K | ||
| Q3 24 | — | $358.0K | ||
| Q2 24 | $-10.7M | $-184.0K | ||
| Q1 24 | $-29.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -75.0% | -12.4% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | -37.3% | -8.3% | ||
| Q1 24 | -108.7% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.3% | 0.9% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.5% | 0.0% |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | -3.07× | 4.69× | ||
| Q1 25 | -0.74× | — | ||
| Q4 24 | — | -1.38× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 18.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
